Delivery Order SPE2DB22D3004-SPE2DB24FRS09
Award Date
8/30/24
Potential Completion Date
9/3/24
Potential Value
$1.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $22,584.93 and a completion date of September 5, 2024. It is a firm fixed-price contract, meaning the price will not change regardless of the contractor's actual costs. This contract is not set aside...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $1,304.72 and a completion date of August 15, 2024. This contract is not set aside for any specific business type. AmerisourceBergen has been awarded numerous federal contracts by defense and civilian...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ondansetron hydrochloride 8 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $6,423.40 and a period of performance through June 4, 2024. It is a firm fixed-price contract, with no set-aside designation. AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the supply of 4 mg Ondansetron Hydrochloride tablets, a medication used to prevent nausea and vomiting, with a ceiling value of $6,368.23. The contract has a period of performance through September 25, 2024 and is a firm-fixed price arrangement. This order is not associated with a set-aside program. AmerisourceBergen is a major...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $8,204.58 and runs through March 4, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ondansetron HCL 4 MG tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $1,985.12 and is a firm fixed-price delivery order, with an ultimate completion date of August 14, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp's Corporate...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Ondansetron HCL 4 mg tablets, a pharmaceutical product used to treat nausea and vomiting. The contract has a ceiling value of $3,564.68 and a completion date of April 19, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,562,473,545 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has a total ceiling value of $14,200.58 and is a firm fixed-price contract with an ultimate completion date of October 16, 2023. The contract is not designated...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $5,519.10 firm fixed price contract is for the supply of 4,565,564,726 units of Ondansetron HCL 8 mg tablets, which are used to treat nausea and vomiting. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of medical...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,958,111 units of Ondansetron HCL 8 mg tablets, a medication used to prevent nausea and vomiting. The contract has a Firm Fixed Price pricing type and a total ceiling value of $17,185.18. It is not set aside for any specific type of business. The contract has an ultimate...